Blood transfusion therapy is the current standard of care to reduce elevated risk of primary and recurrent strokes in children with sickle cell disease. Despite great success, chronic transfusion is not without significant risks and comes with a substantial burden. Individualized cerebral monitoring for goal-oriented therapy may better ensure optimal response to treatment and further mitigate risk of infarctions. In this study, we demonstrate diffuse optical spectroscopies (Diffuse Correlation Spectroscopy and Frequency-Domain Near-infrared Spectroscopy) as a simple and low-cost means for bedside assessments of changes in cerebral blood flow, oxygen extraction, and metabolic rate of oxygen in response to transfusion.
Access to the requested content is limited to institutions that have purchased or subscribe to SPIE eBooks.
You are receiving this notice because your organization may not have SPIE eBooks access.*
*Shibboleth/Open Athens users─please
sign in
to access your institution's subscriptions.
To obtain this item, you may purchase the complete book in print or electronic format on
SPIE.org.
INSTITUTIONAL Select your institution to access the SPIE Digital Library.
PERSONAL Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.